Background
Leishmania donovani
is a protozoan parasite, a primary causative agent of visceral leishmaniasis. Sterol produced via the mevalonate pathway, show differences in composition across biological kingdoms. The specific occurrence of Δ22-unsaturated sterols, containing a double bond at the C-22 position in the side chain occurs in fungi as ergosterol and as stigmasterol in plants. In the present study, we report the identification and functional characterization of a plant-like Cytochrome P450 subfamily CYP710C1 in
L
.
donovani
as the
Leishmania
C-22 desaturase.
Methodology
In silico
analysis predicted the presence of a plant like
CYP710C1
gene that encodes a sterol C-22 desaturase, a key enzyme in stigmasterol biosynthesis. The enzymatic function of recombinant CYP710C1 as C-22 desaturase was determined. To further study the physiological role of CYP710C1 in
Leishmania
, we developed and characterized an overexpressing strain and a gene deletion mutant. C-22 desaturase activity and stigmasterol levels were estimated in the wild-type, overexpressing promastigotes and heterozygous mutants.
Conclusion
We for the first time report the presence of a
CYP710C1
gene that encodes a plant like sterol C-22 desaturase leading to stigmasterol biosynthesis in
Leishmania
. The recombinant CYP710C1 exhibited C-22 desaturase activity by converting β-sitosterol to stigmasterol. Axenic amastigotes showed higher expression of CYP710C1 mRNA, protein and stigmasterol levels compared to the promastigotes. Sterol profiling of CYP710C1 overexpressing
L
.
donovani
and heterozygous mutant parasites demonstrated that CYP710C1 was responsible for stigmasterol production. Most importantly, we demonstrate that these
CYP710C1
overexpressing promastigotes are resistant to amphotericin B, a drug of choice for use against leishmaniasis. We report that
Leishmania
sterol biosynthesis pathway has a chimeric organisation with characteristics of both plant and fungal pathways.